BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20001236)

  • 41. Flow cytometric detection of ZAP-70 in chronic lymphocytic leukemia: correlation with immunocytochemistry and Western blot analysis.
    Slack GW; Wizniak J; Dabbagh L; Shi X; Gelebart P; Lai R
    Arch Pathol Lab Med; 2007 Jan; 131(1):50-6. PubMed ID: 17227123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive value.
    Hus I; Bojarska-Junak A; Dmoszyńska A; Wasik-Szczepanek E; Sieklucka M; Trześniewska W; Glazer M; Roliński J
    Folia Histochem Cytobiol; 2008; 46(2):147-52. PubMed ID: 18519230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia.
    Chantepie SP; Vaur D; Grunau C; Salaün V; Briand M; Parienti JJ; Heutte N; Cheze S; Roussel M; Gauduchon P; Leporrier M; Krieger S
    Leuk Res; 2010 Jun; 34(6):800-8. PubMed ID: 19944462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia.
    el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM
    Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
    McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
    Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
    Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
    N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kolmogorov-Smirnov statistical test for analysis of ZAP-70 expression in B-CLL, compared with quantitative PCR and IgV(H) mutation status.
    Van Bockstaele F; Janssens A; Piette A; Callewaert F; Pede V; Offner F; Verhasselt B; Philippé J
    Cytometry B Clin Cytom; 2006 Jul; 70(4):302-8. PubMed ID: 16906582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.
    Del Poeta G; Del Principe MI; Consalvo MA; Maurillo L; Buccisano F; Venditti A; Mazzone C; Bruno A; Gianní L; Capelli G; Lo Coco F; Cantonetti M; Gattei V; Amadori S
    Cancer; 2005 Dec; 104(12):2743-52. PubMed ID: 16284990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The activity of atorvastatin and rosiglitazone on CD38, ZAP70 and apoptosis in lymphocytes of B-cell chronic lymphocytic leukemia in vitro.
    Yavasoglu I; Sargin G; Kadikoylu G; Karul A; Bolaman Z
    Med Oncol; 2013; 30(3):603. PubMed ID: 23686733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical analysis of ZAP-70 expression in chronic lymphocytic leukemia.
    Korać P; Ajduković R; Kardum Paro MM; Jaksić B; Dominis M
    J Mol Histol; 2009 Feb; 40(1):81-6. PubMed ID: 19267204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541.
    López-Guerra M; Roué G; Pérez-Galán P; Alonso R; Villamor N; Montserrat E; Campo E; Colomer D
    Clin Cancer Res; 2009 Apr; 15(8):2767-76. PubMed ID: 19351760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Flow cytometry for ZAP-70: New colors for chronic lymphocytic leukemia.
    Wiestner A
    Cytometry B Clin Cytom; 2006 Jul; 70(4):201-3. PubMed ID: 16906579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
    Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
    Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia.
    Trojani A; Montillo M; Nichelatti M; Tedeschi A; Colombo C; Veronese S; Mura MA; Ricci F; Scarpati B; Colosimo A; Lodola M; Morra E
    Cancer Biomark; 2010; 6(1):1-9. PubMed ID: 20164537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.
    Nückel H; Hüttmann A; Klein-Hitpass L; Schroers R; Führer A; Sellmann L; Dührsen U; Dürig J
    Leuk Lymphoma; 2006 Jun; 47(6):1053-61. PubMed ID: 16840197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.
    Pickering BM; de Mel S; Lee M; Howell M; Habens F; Dallman CL; Neville LA; Potter KN; Mann J; Mann DA; Johnson PW; Stevenson FK; Packham G
    Oncogene; 2007 Feb; 26(8):1166-77. PubMed ID: 16924235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression.
    Podhorecka M; Klimek P; Kowal M; Chocholska S; Bojarska-Junak A; Dmoszynska A
    Acta Haematol; 2010; 123(3):171-8. PubMed ID: 20224269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The distribution and potential prognostic value of SMAD protein expression in chronic lymphocytic leukemia.
    Witkowska M; Majchrzak A; Cebula-Obrzut B; Wawrzyniak E; Robak T; Smolewski P
    Tumour Biol; 2017 Mar; 39(3):1010428317694551. PubMed ID: 28349818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.